你离妊娠期糖尿病有多近?
Najma N Abdullahi1, Erika Werner2, Patrick Vivier2
1Wright State Medical School, Dayton, OH.
Rhode Island medical journal (2013)
|June 27, 2023
概括
这项研究发现,孕妇与食物来源的距离以及她们患妊娠期糖尿病 (GDM) 的风险之间没有联系. 需要进一步的研究来了解GDM风险因素并改善孕产妇健康结果.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 环境健康 环境健康
背景情况:
- 孕期糖尿病 (GDM) 是一个日益严重的公共卫生问题.
- 了解GDM的环境风险因素对于制定有针对性的干预措施至关重要.
- 之前的研究集中在食物环境密度上,但近距离也可能起作用.
研究的目的:
- 调查食物来源的接近与患妊娠糖尿病 (GDM) 的风险之间的关联.
- 为了确定距离快餐店,超市或农民市场/社区花园的距离是否与GDM风险有关.
主要方法:
- 利用罗德岛出生证明数据 (2015-2016) 对20129个出生.
- 进行了近距离分析,以测量从家庭地址到最近的食物来源的距离.
- 采用多变量物流回归来评估食物来源距离与GDM风险之间的关联.
主要成果:
- 7.2%的出生 (1,447) 被诊断出患有GDM.
- 食物来源的距离因保险,教育和种族/种族而异.
- 在调整后的模型中,没有发现任何食物来源的接近与GDM风险之间的统计学意义上的关联.
结论:
- 在这项研究中测量到的食物来源的接近与妊娠期糖尿病风险没有显著关联.
- 需要对其他环境和社会经济因素进行进一步的研究.
- 研究结果表明,需要重新评估目前用于预防和管理GDM的公共卫生策略.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Pathophysiology of Diabetes
1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes: Symptoms, Diagnosis, and Complications
605
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
605
Hypoglycemia and Glucagon
306
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
306
Oral Hypoglycemic Agents: Glinides
189
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
189


